| UniProt ID | DPOE3_HUMAN | |
|---|---|---|
| UniProt AC | Q9NRF9 | |
| Protein Name | DNA polymerase epsilon subunit 3 | |
| Gene Name | POLE3 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 147 | |
| Subcellular Localization | Nucleus . | |
| Protein Description | Forms a complex with DNA polymerase epsilon subunit CHRAC1 and binds naked DNA, which is then incorporated into chromatin, aided by the nucleosome-remodeling activity of ISWI/SNF2H and ACF1.. | |
| Protein Sequence | MAERPEDLNLPNAVITRIIKEALPDGVNISKEARSAISRAASVFVLYATSCANNFAMKGKRKTLNASDVLSAMEEMEFQRFVTPLKEALEAYRREQKGKKEASEQKKKDKDKKTDSEEQDKSRDEDNDEDEERLEEEEQNEEEEVDN | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MAERPEDLN ------CCCCHHHCC | 22.85 | 19413330 | |
| 20 | Ubiquitination | AVITRIIKEALPDGV HHHHHHHHHHCCCCC | 34.27 | - | |
| 31 | Acetylation | PDGVNISKEARSAIS CCCCCCCHHHHHHHH | 52.15 | 25953088 | |
| 31 | Ubiquitination | PDGVNISKEARSAIS CCCCCCCHHHHHHHH | 52.15 | 21890473 | |
| 35 | Phosphorylation | NISKEARSAISRAAS CCCHHHHHHHHHHHH | 36.68 | 20860994 | |
| 38 | Phosphorylation | KEARSAISRAASVFV HHHHHHHHHHHHHHH | 18.64 | 20860994 | |
| 62 | Ubiquitination | FAMKGKRKTLNASDV CHHCCCCCCCCHHHH | 61.93 | - | |
| 63 | Phosphorylation | AMKGKRKTLNASDVL HHCCCCCCCCHHHHH | 29.31 | 22617229 | |
| 67 | Phosphorylation | KRKTLNASDVLSAME CCCCCCHHHHHHHHH | 27.46 | 30576142 | |
| 71 | Phosphorylation | LNASDVLSAMEEMEF CCHHHHHHHHHHHHH | 25.97 | 20068231 | |
| 83 | Phosphorylation | MEFQRFVTPLKEALE HHHHHHHHHHHHHHH | 21.86 | 18669648 | |
| 86 | Ubiquitination | QRFVTPLKEALEAYR HHHHHHHHHHHHHHH | 41.99 | 21890473 | |
| 92 | Phosphorylation | LKEALEAYRREQKGK HHHHHHHHHHHHHCC | 10.79 | 23312004 | |
| 114 | Phosphorylation | KKDKDKKTDSEEQDK HHHHCCCCCHHHHHH | 50.96 | 28985074 | |
| 116 | Phosphorylation | DKDKKTDSEEQDKSR HHCCCCCHHHHHHHC | 48.54 | 30576142 | |
| 122 | Phosphorylation | DSEEQDKSRDEDNDE CHHHHHHHCCCCCHH | 53.94 | 26503892 | |
| 123 | Methylation | SEEQDKSRDEDNDED HHHHHHHCCCCCHHH | 58.01 | 115488093 | |
| 133 | Methylation | DNDEDEERLEEEEQN CCHHHHHHHHHHHHH | 45.40 | 115488085 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of DPOE3_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of DPOE3_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of DPOE3_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| SMCA5_HUMAN | SMARCA5 | physical | 10880450 | |
| BAZ1A_HUMAN | BAZ1A | physical | 10880450 | |
| CHRC1_HUMAN | CHRAC1 | physical | 10880450 | |
| BAZ1A_HUMAN | BAZ1A | physical | 14759371 | |
| SMCA5_HUMAN | SMARCA5 | physical | 14759371 | |
| DPOE4_HUMAN | POLE4 | physical | 10801849 | |
| DPOE2_HUMAN | POLE2 | physical | 10801849 | |
| DPOE1_HUMAN | POLE | physical | 21705323 | |
| A4_HUMAN | APP | physical | 21832049 | |
| DPOE4_HUMAN | POLE4 | physical | 22939629 | |
| ANXA6_HUMAN | ANXA6 | physical | 22863883 | |
| SIAS_HUMAN | NANS | physical | 22863883 | |
| CHRC1_HUMAN | CHRAC1 | physical | 25416956 | |
| ATAD2_HUMAN | ATAD2 | physical | 26344197 | |
| DPOE1_HUMAN | POLE | physical | 26344197 | |
| CHRC1_HUMAN | CHRAC1 | physical | 21516116 |
| Kegg Disease | |
|---|---|
| There are no disease associations of PTM sites. | |
| OMIM Disease | |
| There are no disease associations of PTM sites. | |
| Kegg Drug | |
| There are no disease associations of PTM sites. | |
| DrugBank | |
| DB00242 | Cladribine |
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-83 AND SER-122, AND MASSSPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-122, AND MASSSPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-122, AND MASSSPECTROMETRY. | |